Côte d'Ivoire vs Cyprus: Antimicrobial resistance or decreased susceptibiity (DS/R) to
Côte d'Ivoire
0
in 2020
Cyprus
0
in 2020
Côte d'Ivoire rank
43rd
Cyprus rank
43rd
Antimicrobial resistance or decreased susceptibiity (DS/R) to over time
- Côte d'Ivoire
- Cyprus
How they compare
Côte d'Ivoire currently reports 0 against 0 in Cyprus, a difference of 0.
The two have swapped places 2 times across 6 shared years of data; in 2013 it was Cyprus ahead.
Côte d'Ivoire ranks 43rd and Cyprus ranks 43rd of 54 countries.
Cyprus has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Côte d'Ivoire | Cyprus | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 8.73 | 10.67 | 1.93 | Cyprus |
| 2020s | 0 | 0 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antimicrobial resistance or decreased susceptibiity (ds/r) to, Côte d'Ivoire or Cyprus?
- Côte d'Ivoire, at 0 against 0 in Cyprus as of 2020.
- What is the difference in antimicrobial resistance or decreased susceptibiity (ds/r) to between Côte d'Ivoire and Cyprus?
- 0, with Côte d'Ivoire ahead.
- How many years of comparable data are there for Côte d'Ivoire and Cyprus?
- 6 years are reported by both, from 2013 to 2020.
- How do Côte d'Ivoire and Cyprus rank globally for antimicrobial resistance or decreased susceptibiity (ds/r) to?
- Côte d'Ivoire ranks 43rd and Cyprus ranks 43rd of 54 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion). Statizoid refreshes it automatically from the source and publishes the full history for both places.